Male and female adults whose fasting or postprandial blood glucose in borderline or high levels, and healthy male and female adults. Those who are planning to become pregnant, expectant or nursing mothers, and breastfeeding women are excluded.
Conditions
Interventions
None listed
Sponsors
Kyushu University
Evaluation Center of Health and Nutrition Inc. Kenichi Kakino
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (PICOS) P (Participant): Male and female adults whose fasting or postprandial blood glucose level: 110-125 mg/dl, 75gOGTT 2 hour after value: 110-125 mg/dl, casual blood glucose level: 140-199 mg/dl, and healthy male and female adults. Minors, pregnant women (including those planning pregnant), lactating mothers, patients with diabetes mellitus, BMI less than 18.5, 30 or above are excluded. I (Intervention): Foods containing barley-derived beta-glucan (regardless of food form) should be taken orally. The duration of intake is one time. Studies with unknown barley-derived beta-glucan content are excluded. C (Comparison): Comparison target, Intake of barley-derived beta-glucan-free placebo O (Outcome measurement): The primary outcome is the evaluated value of the effect of intake of barley-derived beta-glucan on Area under the blood concentration curve (AUC) and the postprandial blood glucose levels. S (Study design): Randomised controlled trials are conducted. A significant difference test is performed on the test results by statistical analysis. The test arm must contain a food or beverage containing barley-derived beta-glucan. Intervention trials without a placebo group and studies using foods with multiple ingredients other than barley-derived beta-glucan as functional components are not included. Only peer-reviewed original papers are eligible.
Exclusion criteria
Exclusion criteria: Trials that include women who are pregnant or breastfeeding, women who are planning to become pregnant, or people who are being treated for hypertension Studies with unknown barley-derived beta-glucan content Papers citing the test results of the original paper, explanatory papers, abstracts of conference presentations, conference proceedings
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The effect of intake of barley-derived beta-glucan on Area under the blood concentration curve (AUC) and the postprandial blood glucose levels | — |
Countries
Japan
Contacts
Public ContactSeiichi Hattori
Kurume Research Park Co., Ltd. Bio Project Division
Outcome results
None listed